Cardiff Oncology, Inc. short interest in 2024
In 2024, Cardiff Oncology, Inc.'s disclosed short interest ran from 2.56% of shares outstanding on 12 Jan 2024 to 18.59% on 31 Dec 2024, a change of +16.03 percentage points. The year's high was 19.45% on 13 Dec 2024 and its low 2.56% on 12 Jan 2024, averaging 11.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.01 days on 30 Aug 2024. Full history: Cardiff Oncology, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 2.56% (12 Jan 2024)
- End of year
- 18.59% (31 Dec 2024)
- Change
- +16.03 pp
- High
- 19.45% (13 Dec 2024)
- Low
- 2.56% (12 Jan 2024)
- Average
- 11.15%
- Highest days to cover
- 25.01 (30 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 2.56% | 7.22 | |
| 31 Jan 2024 | 2.89% | 14.04 | |
| 15 Feb 2024 | 2.66% | 4.20 | |
| 29 Feb 2024 | 2.58% | 3.64 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 6.30% | 1.00 | |
| 28 Mar 2024 | 7.63% | 2.37 | |
| 15 Apr 2024 | 8.93% | 4.39 | |
| 30 Apr 2024 | 9.88% | 5.73 | |
| 15 May 2024 | 10.34% | 5.46 | 10-Q filed, results (8-K) |
| 31 May 2024 | 9.97% | 10.74 | |
| 14 Jun 2024 | 9.03% | 8.41 | |
| 28 Jun 2024 | 9.44% | 3.52 | |
| 15 Jul 2024 | 11.45% | 7.91 | |
| 31 Jul 2024 | 12.93% | 16.61 | |
| 15 Aug 2024 | 14.43% | 12.37 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 14.83% | 25.01 | |
| 13 Sep 2024 | 14.81% | 16.14 | |
| 30 Sep 2024 | 14.67% | 12.67 | |
| 15 Oct 2024 | 15.71% | 13.73 | |
| 31 Oct 2024 | 17.33% | 9.56 | |
| 15 Nov 2024 | 15.09% | 5.70 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 16.00% | 15.95 | |
| 13 Dec 2024 | 19.45% | 1.48 | |
| 31 Dec 2024 | 18.59% | 4.94 |
See also: Cardiff Oncology, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.